162 related articles for article (PubMed ID: 18566243)
1. 5-Aminolaevulinic acid peptide prodrugs enhance photosensitization for photodynamic therapy.
Bourré L; Giuntini F; Eggleston IM; Wilson M; MacRobert AJ
Mol Cancer Ther; 2008 Jun; 7(6):1720-9. PubMed ID: 18566243
[TBL] [Abstract][Full Text] [Related]
2. A quantitative assessment of protoporphyrin IX metabolism and phototoxicity in human skin following dose-controlled delivery of the prodrugs 5-aminolaevulinic acid and 5-aminolaevulinic acid-n-pentylester.
Gerscher S; Connelly JP; Beijersbergen Van Henegouwen GM; MacRobert AJ; Watt P; Rhodes LE
Br J Dermatol; 2001 May; 144(5):983-90. PubMed ID: 11359385
[TBL] [Abstract][Full Text] [Related]
3. Enhanced porphyrin accumulation using dendritic derivatives of 5-aminolaevulinic acid for photodynamic therapy: an in vitro study.
Battah S; O'Neill S; Edwards C; Balaratnam S; Dobbin P; MacRobert AJ
Int J Biochem Cell Biol; 2006; 38(8):1382-92. PubMed ID: 16546435
[TBL] [Abstract][Full Text] [Related]
4. Peptide-targeted dendrimeric prodrugs of 5-aminolevulinic acid: A novel approach towards enhanced accumulation of protoporphyrin IX for photodynamic therapy.
Tewari KM; Dondi R; Yaghini E; Pourzand C; MacRobert AJ; Eggleston IM
Bioorg Chem; 2021 Apr; 109():104667. PubMed ID: 33611140
[TBL] [Abstract][Full Text] [Related]
5. Relationship of protoporphyrin IX synthesis to photodynamic effects by 5-aminolaevulinic acid and its esters on various cell lines derived from the skin.
Lee JB; Choi JY; Chun JS; Yun SJ; Lee SC; Oh J; Park HR
Br J Dermatol; 2008 Jul; 159(1):61-7. PubMed ID: 18489589
[TBL] [Abstract][Full Text] [Related]
6. Improving in vitro photodynamic therapy through the development of a novel iron chelating aminolaevulinic acid prodrug.
Curnow A; Perry A; Wood M
Photodiagnosis Photodyn Ther; 2019 Mar; 25():157-165. PubMed ID: 30553949
[TBL] [Abstract][Full Text] [Related]
7. Protoporphyrin IX enhancement by 5-aminolaevulinic acid peptide derivatives and the effect of RNA silencing on intracellular metabolism.
Bourré L; Giuntini F; Eggleston IM; Wilson M; MacRobert AJ
Br J Cancer; 2009 Mar; 100(5):723-31. PubMed ID: 19240715
[TBL] [Abstract][Full Text] [Related]
8. The use of dipeptide derivatives of 5-aminolaevulinic acid promotes their entry to tumor cells and improves tumor selectivity of photodynamic therapy.
Di Venosa G; Vallecorsa P; Giuntini F; Mamone L; Batlle A; Vanzuli S; Juarranz A; MacRobert AJ; Eggleston IM; Casas A
Mol Cancer Ther; 2015 Feb; 14(2):440-51. PubMed ID: 25519699
[TBL] [Abstract][Full Text] [Related]
9. Poly(L-histidine)-tagged 5-aminolevulinic acid prodrugs: new photosensitizing precursors of protoporphyrin IX for photodynamic colon cancer therapy.
Johnson RP; Chung CW; Jeong YI; Kang DH; Suh H; Kim I
Int J Nanomedicine; 2012; 7():2497-512. PubMed ID: 22679363
[TBL] [Abstract][Full Text] [Related]
10. Improved peptide prodrugs of 5-ALA for PDT: rationalization of cellular accumulation and protoporphyrin IX production by direct determination of cellular prodrug uptake and prodrug metabolization.
Giuntini F; Bourré L; MacRobert AJ; Wilson M; Eggleston IM
J Med Chem; 2009 Jul; 52(13):4026-37. PubMed ID: 19492812
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of 5-aminolaevulinic acid/3-hydroxypyridinone conjugates as potential photodynamic therapeutical agents.
Zhu CF; Battah S; Kong X; Reeder BJ; Hider RC; Zhou T
Bioorg Med Chem Lett; 2015 Feb; 25(3):558-61. PubMed ID: 25556100
[TBL] [Abstract][Full Text] [Related]
12. Topical application of 5-aminolevulinic acid hexyl ester and 5-aminolevulinic acid to normal nude mouse skin: differences in protoporphyrin IX fluorescence kinetics and the role of the stratum corneum.
van den Akker JT; Iani V; Star WM; Sterenborg HJ; Moan J
Photochem Photobiol; 2000 Nov; 72(5):681-9. PubMed ID: 11107855
[TBL] [Abstract][Full Text] [Related]
13. Penetration enhancement of two topical 5-aminolaevulinic acid formulations for photodynamic therapy by erbium:YAG laser ablation of the stratum corneum: continuous versus fractional ablation.
Forster B; Klein A; Szeimies RM; Maisch T
Exp Dermatol; 2010 Sep; 19(9):806-12. PubMed ID: 20636354
[TBL] [Abstract][Full Text] [Related]
14. 5-Aminolevulinic acid (ALA)-induced protoporphyrin IX fluorescence and photodynamic effects in the rat bladder: an in vivo study comparing oral and intravesical ALA administration.
Chang SC; Buonaccorsi G; MacRobert AJ; Bown SG
Lasers Surg Med; 1997; 20(3):254-64. PubMed ID: 9138254
[TBL] [Abstract][Full Text] [Related]
15. Zwitterionic stealth peptide-capped 5-aminolevulinic acid prodrug nanoparticles for targeted photodynamic therapy.
Wu J; Lin Y; Li H; Jin Q; Ji J
J Colloid Interface Sci; 2017 Jan; 485():251-259. PubMed ID: 27676086
[TBL] [Abstract][Full Text] [Related]
16. Photosensitization and mechanism of cytotoxicity induced by the use of ALA derivatives in photodynamic therapy.
Casas A; Fukuda H; Di Venosa G; Batlle A
Br J Cancer; 2001 Jul; 85(2):279-84. PubMed ID: 11461090
[TBL] [Abstract][Full Text] [Related]
17. Comparison of 5-aminolevulinic acid and its hexylester mediated photodynamic action on human hepatoma cells.
Ren QG; Wu SM; Peng Q; Chen JY
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Sep; 34(5):650-4. PubMed ID: 12198571
[TBL] [Abstract][Full Text] [Related]
18. A comparison of 5-aminolaevulinic acid- and its heptyl ester: dark cytotoxicity and protoporphyrin IX synthesis in human adenocarcinoma WiDr cells and in athymic nude mice healthy skin.
Pudroma X; Moan J; Ma LW; Iani V; Juzeniene A
Exp Dermatol; 2009 Nov; 18(11):985-7. PubMed ID: 19469901
[TBL] [Abstract][Full Text] [Related]
19. Topical application of 5-aminolevulinic acid and its methylester, hexylester and octylester derivatives: considerations for dosimetry in mouse skin model.
Juzeniene A; Juzenas P; Iani V; Moan J
Photochem Photobiol; 2002 Sep; 76(3):329-34. PubMed ID: 12403455
[TBL] [Abstract][Full Text] [Related]
20. Macromolecular delivery of 5-aminolaevulinic acid for photodynamic therapy using dendrimer conjugates.
Battah S; Balaratnam S; Casas A; O'Neill S; Edwards C; Batlle A; Dobbin P; MacRobert AJ
Mol Cancer Ther; 2007 Mar; 6(3):876-85. PubMed ID: 17363482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
